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Foreword by Ulrich Laaser  
 
Dr. Hans Stein has been on the European Union (EU)-Health stage for more than 25 years, 
starting with the very first Health Council in 1977. As an official of the German Health 
Ministry (Head of the EU Health Policy Unit) he represented Germany in countless EU 
(Council and Commission) committees and working groups concerning health policy and 
public health research. He not only organised the Health Council of four German EU 
presidencies, but also published a large number of articles mainly in international journals and 
books. After his retirement in 2002, Dr. Stein continued as a free lance consultant to a number 
of EU institutions and a lecturer in German, Dutch, Austrian, and English Schools of Public 
Health. 
Personally, I probably met Hans Stein the first time in 1977 when in West Germany a 
discussion started about a “big” population study on cardiovascular health. He worked already 
for several years in the Ministry of Health (the name of the ministry at that time may have 
been more complex and I forgot it) but, different from many political administrators, he was 
fascinated by contents and not by formalities. He paved the way for the German 
Cardiovascular Prevention Study (GCP) targeting five regions with together around one 
million population for more than a decade (1979-1994). Hans Stein started his long chain of 
contributions to population health and health policy with a presentation in my then High 
Blood Pressure Department in Heidelberg and I remember how difficult it was to convince 
him to speak in public about prevention. That changed later completely when he became a 
European figure representing the German Government in the endless and tiring deliberations 
foregoing the milestone treaty of Maastricht. I shall never forget how Dr. Stein presented a 
historical dialogue with his former Dutch colleague Jos Draijer at the 25
th
 anniversary of the 
Treaty at a celebration in the very city of Maastricht. Hans Stein remained an engaged sceptic 
with an insurmountable enthusiasm, truly a rare mélange, obvious also from his review below 
of the European health policy development since Maastricht. 
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Abstract 
Aim: The article contains a personal view of the history as well as the future of the European 
Union‟s (EU) health policy. Describing and evaluating the developments on the road from the 
Treaty of Maastricht to a new Europe it asks and tries to answer the question if we – 
especially the EU Member States – really know where we want to go to and how to get there.  
Method: Based on personal experiences, countless EU documents, as well as scientific 
publications the paper shows the impact EU Health policy has had in the Member States in 
the past.  
Historical development: Considering that the legal basis for health has been and remains to 
be very weak limiting EU action to support, coordinate, and supplement actions of Member 
States – which, as a rule, still consider health to be first and foremost a national responsibility 
and therefore do not want interference from international institutions – the amount and 
content of EU health activities in the past years has been quite remarkable. Health policy may 
not be an EU priority and as a crosscutting policy sector it is dominated by many other EU 
policies. However, especially the “hard law” regulations and directives of the Internal Market 
give EU the power and competence to achieve health objectives. The size of this growing 
influence is shown by direct interventions, made possible by the legal acts to improve 
economic policy coordination. Health and health care in this context are considered as  a key 
policy area for economic growth and EU macroeconomic policy. On the other hand, there is a 
risk that such regulations affecting health policy and population health may be dominated too 
much by economic institutions and their interests, whereas health authorities play only a 
minor role to date.  
Conclusion: For the future of EU health policy it is essential that its position is considerably 
strengthened, in order to assure that health interests of the EU population are sufficiently 
safeguarded. 
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Introduction 
As a rule, a 20
th
 anniversary, especially when it concerns an event considered to be a 
historical landmark, is a cause for celebration. The Treaty of Maastricht was finally negotiated 
in an intergovernmental conference by the Member States of the European Union (EU) and 
signed on the 7
th
 of February 1992 in Maastricht, The Netherlands (1). It came into force on 
the 1
st
 of November 1993 after it had been ratified in all Member States by national 
parliaments, in some cases adopted even by a population referendum.  
It is not only a cornerstone in the general development of the European Union, comparable to 
the establishment of an economic and monetary union  with a common currency, but it also 
contains for the first time a specific legal basis for health as a European issue. It is worthwhile 
noting that, this process was dominated by the governments of the Member States. 
Commission and European Parliament participated on the side lines with very limited power 
to influence content and process. Nevertheless, this event certainly would have deserves to be 
celebrated. But, surprisingly, except for some small meetings in Maastricht, initiated by local 
institutions, there were no celebrations by the European Union in Brussels, or in national 
capitals. 
This situation should be a cause for concern. Is it considered to be so critical that nobody 
wants to be reminded of how, when and where European integration started? Were the 
experiences during the last 20 years in general, as well as with the implementation of the 
health mandate specifically that bad and negative? Has the European vision got lost or was it 
just forgotten? Has The European dream ended? Or, is it that the EU has too big difficulties 
occupying the minds in adapting itself to the present situation characterized by the economic 
crisis and globalisation? 
 
Looking back as a base for future developments 
It is the purpose of this article not only to describe how the EU health policy has developed in 
the 20 years since the Maastricht treaty was signed, but also to develop concepts for the 
future. 
Whether and how much it was a success story and what future perspectives are needed and 
realistic, cannot be judged only by looking at health issues. No EU policy field develops in 
isolation. Especially in health with its horizontal character progress depends to a great deal on 
the overall EU development, its problems, and how these are solved. The present EU crisis, in 
many ways related to the economic situation, was not caused by health issues but health 
problems and even national health policies are affected by the crisis and the measures taken to 
improve the situation. “Health in all policies” (2) is not only a mandate, but also a description 
of the situation. 
It will be shown how  the newly created instruments to establish  a “European Economic 
Governance” such as the   European Semester (3), the Stability Pact (4)  and others not only 
go far beyond the existing legal base, but will influence national health systems  and  policies 
by increasing  the Commission‟s  power to intervene at a national level. 
 
Lack of interest in the past 
The existing lack of interest in the historic development of the European integration in 
general, and especially in the EU health policies may be regretted, but it can be explained by 
two interrelated developments: 
- Lack of positive commitment of EU citizens to European unification, and; 
- EU enlargement implies growing economic gap between Member States. 
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Lack of commitment by the citizens 
The project of European unification faces presently the biggest existential crisis of its history. 
Nobody really knows when and how the crisis can be overcome or, at least, be mitigated. 
Timothy Garton Ash (5) in an essay “The Crisis of Europe” describes in great detail how the 
Union came together and why right now it seems to be falling apart. In his view “The project 
of European unification for about 40 years could rely on at least a passive consensus among 
most of Europe‟s national publics”, today there is a lack of commitment to European 
integration nearly everywhere. It is obvious that a growing number of citizens in many 
countries do not believe anymore that the EU can at least contribute to solving their problems. 
Even worse, they consider the EU itself to be the problem.  These sceptical and critical views 
about the EU have existed in many countries for quite a number of years.  But, Eurobarometer 
(6) as well as national polls, especially the results of the elections 2014 for the European 
Parliament, show that a growing number of citizens in many countries have lost confidence in 
the EU. Surprisingly, this feeling exists even in Germany or the Netherlands, two signatory 
nations of the Maastricht Treaty, for a long time firm believers in European integration, 
including even a Political Union, countries that are not suffering from the present economic 
crisis. 
European integration has been rightly described as a project of elites with little even indirect 
participation of the citizens. They were seldom asked if they agreed to European solutions. 
And they were certainly never asked, if they wanted European solutions in health matters.  
Had this been the case, a clear “No” would have been the answer, even if they could not have 
imagined how these solutions would look like. 
 
EU enlargement and the economic gap 
In 1993, only 12 Member States negotiated and signed the Maastricht Treaty. Since then, we 
have had three new treaties – of Amsterdam, Nice and the still valid one of Lisbon (7) – as 
well as a failed attempt to establish a European Constitution. More importantly, the EU has 
increased tremendously in size. From 1993 to 2014, altogether 16 new states have joined the 
EU and even more association negotiations are going on and will soon lead to even more 
Member States (MS). At the same time some MS – especially the United Kingdom – consider 
to leave the EU unless their special interests are taken care of. For the new MS, the date of 
their own accession as well as a solution of their present day problems are more important 
than a Treaty which was signed 20 years ago. 
The astonishing and unexpected enlargement and expansion of the EU from original six to 
now 29 and possibly soon 35 Member States in a few years is not a question of numbers 
alone. Whereas EU structures and mechanisms, originally designed for only six MS have 
largely remained unchanged, this enormous growth combined with a financial and economic 
crisis has created big, yet unsolved problems. On the one hand, there is a growing small vs. 
big MS situation. Whereas eight MS have a population of five million or less (Luxemburg, 
Malta, and Cyprus being the smallest with only 0.5 million inhabitants), seven MS have a 
population between 6-10 million, and only 12 have more than 10 million. Small size 
populations lead to small size economies. There are enormous differences in the present 
economic situation of some, often new MS. In health, this means that not all MS have 
sufficient financial and personal resources to offer their population all health services that are 
needed. This has already led to a growing „health gap‟ (8).  Reducing these health inequalities 
is essential in that it will contribute to social cohesion, i.e. reducing poverty and social 
exclusion. It requires a new dimension of EU solidarity including support and assistance. The 
classical EU instruments of cooperation and coordination are not sufficient any more to cope 
with the present situation. 
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Weaknesses and shortcomings of EU health policy 
 
Health – an EU priority? 
Health has never been a priority of European integration and it is highly improbable that it 
will ever become so in the future. Despite a number of positive achievements in the past, 
health has not become a central objective of EU policy making. Contrary to environmental 
policy or research – to name just two health-related similar policy areas – health has not been 
named in any of the various EU treaties as an EU objective. In Article 3 of the Treaty of 
Maastricht, where the purpose of the various EU policy areas has been described, it states 
about health as follows: “A contribution to the attainment of a high level of health 
protection”, which is not exactly a very ambitious objective. 
On the contrary, whenever in the past years a reduction of EU activities and competence has 
been demanded by MS, health always has been a strong candidate, offered even by the 
Commission. With this background, it is not surprising that the power and influence of the 
Health Commissioner and his General Directorate has never been high. His responsibilities 
were always limited, and the financial and personal resources are small, especially when 
compared with areas like agriculture or research.  It is not surprising that big Member States 
in the usual battle to get an influential Commissioner have never shown any interest to get this 
office. In the past twenty, years Health Commissioners have therefore come from smaller 
countries like Greece, Ireland, Cyprus, and Malta.  
The same applies to the new Commission coming into power in September 2014. The new 
Commissioner for Health and Food Safety, Vytenis Andriukaitis, comes from Lithuania, also 
a small country. But, differing from all his predecessors, he has experience in EU matters as 
well as a very convincing health background: he is a surgeon and was Lithuanian Minister of 
Health and, as such, responsible for an impressive health agenda during the Lithuanian EU 
Presidency in 2013. As health remains an independent EU policy area – combined with food 
safety, for a long time a major EU priority – the expectation can be justified that health might 
become more powerful in the future. 
The Commission has always been called the „Guardian of the Treaty‟ (9), from whom it was 
expected to work for more integration. However, as far as health is concerned, it has shown 
only little interest in the past to improve the status of health as a European topic. It appears 
that most if not all successful proposals have come from others; in 1977, for example, a 
Belgian initiative to establish a Health Council and in 1985 a French proposal in the Rome 
Summit to establish „Europe against Cancer‟ as a European responsibility (both, by the way, 
many years before health was established formally as a European task in the Maastricht 
Treaty). Furthermore, in 1995, the initiative of the European Parliament to strengthen the EU 
health Mandate and legal competence resulted in the Amsterdam Treaty 1997; and, finally, 
the many decisions of the European Court of Justice, beginning 1998 with the famous “Kohll 
and Decker” cases about patient mobility.  The last phase started in 2012 with various summit 
decisions to establish a „European Economic Governance‟ with new instruments including 
“Health care as an answer to the economic and financial crisis, going far beyond the existing 
EU legal base” (10). 
It seems that others discovered much earlier than the Commission the health potential of the 
main EU objective, namely the Internal Market. 
 
Health and the internal market  
It is often overlooked that national health systems, however differently they are organised and 
financed, are strongly related to and have been integrated into the Internal Market with its 
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four freedoms (11) embracing the free movement of goods (pharmaceuticals and health 
technology), free services (physicians, nurses), cross-border capital (e.g. investing in 
rehabilitation clinics), and people, i.e. patients looking for treatment outside their home 
country. 
Right from the beginning, health systems have been influenced and even regulated to some 
extent by regulations and directives of the EU market and the competition therein. Health care 
is, and it has always been, a central element of European and national economies. It is a big, 
possibly the biggest part of the Internal Market and it is permanently growing. About 8.5% of 
the national gross domestic product is, on average, spent for health. In Germany, this means 
every year more than 250 billion Euro. Millions of people – especially doctors and nurses – 
work in the health care systems. In Germany, about 12% of the working population is 
employed in the health sector (12). Many of them, especially in the new MS, make 
increasingly use of their right of free movement and work in other EU countries. In the 
receiving countries this contributes to solving the existing shortage problems, whereas at the 
same time it leads to growing difficulties in their home countries. 
The main objective of the regulations and directives, the most effective EU tools, is to 
establish a functional internal market (13).They apply fully to the health systems and 
influence the development and content of national health policy. In addition, they are a 
powerful treaty base for influencing and even removing those MS policies such as health that 
might interfere with the aims of the Internal Market. 
Scott Greer (14) describes the results and consequences of the Maastricht Treaty in his essay 
„Glass half empty‟: “The Euro zone and the Internal Market overshadow the health effects of 
Maastricht: It is comparatively easy to find the treaty authority for legislation promoting the 
internal market and EU law and courts are sceptical of public health or other rationales for 
legislation impeding the markets development”. He names as prominent examples the patient 
mobility decisions of the European Court of Justice, which culminated in the Directive on 
Patients‟ Rights in Cross Border Mobility (15). Furthermore, the application of competition 
and the state law for health care providers, and the integration of pharmaceuticals‟ regulation 
around the European Medicines Agency. Finally, he summarises his considerations about the 
effects of the Maastricht Treaty on health as follows: “The first mention of health was the 
harbinger of more effective promotion of health issues within EU policy making. In time, 
however, the Internal Market and the single currency have had the biggest health 
consequences”. This was not really what the MS had in mind when in 1992 they established a 
specific EU Public Health Mandate. 
 
Position and interests of Member States 
Health has always been considered to be first and foremost a national responsibility. States all 
over the world with hardly any exception want to keep their complete and undiminished 
integrity and full autonomy to organize and run their health systems the way they want it. 
Health systems, different as they are, often are considered as a part of the national heritage 
and culture. Countries do not want any interference from outside, be it by the EU, or be it by 
the WHO, which by the way is more accepted than EU institutions, but not more effective. 
For many years national governments – in full agreement with their citizens and the medical 
professions – have jealously and on the whole successfully prevented the transfer of any 
substantial health policy issues to a supra-national level, except for the indirect effects of the 
Internal Market as discussed above. They, therefore, still have a great difficulty in accepting 
health policy as a matter of the EU concern. It seems that health policy is one of the last 
realms and retreats of national policy competence which had to be defended. 
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It seems also that health policy is a political sector which more than others absorbs and 
reflects national developments, traditions, and cultures. Health systems are seen as the result 
of decades of development and the individual response to a country‟s social situation and 
profile. The answers given a long time ago by Bismarck and later by Beveridge regarding 
health seem to be sacrosanct even if a lot has changed since their time. Safeguarding the 
pluralism of national health systems is considered to be a value by itself which has to be kept 
safeguarded at all costs against influence from outside even if the problems faced everywhere 
are quite identical and the solutions are at least similar. It seems to be overlooked that the EU 
might be a supporting strategic partner to overcome vested stakeholder interests that at the 
national level would not be possible. 
These popular but nevertheless antiquated views neglect a number of essential facts important 
for health. Individual MS alone cannot cope sufficiently with outbreaks of infectious diseases 
like H1N1, food safety issues, biological or chemical terrorism and health threats from 
climate change. Growing new health dangers and threats which „don‟t respect borders‟ is a 
common saying, presently Ebola being an example (16). The development and evaluation of 
new technologies and pharmaceuticals especially combating rare diseases and the 
establishment of whole new areas such as e-health and telemedicine expand beyond the 
national level. Therefore, possibly the best argument for the need of an EU health policy is the 
undisputed fact that health is influenced and  determined to a great extent by factors and 
policies far outside national health care systems namely environment, work, transport, 
education, research and, most importantly, the economic situation of society and the 
individual. As all these policy areas are shaped more and more at the EU or even global level 
in different ways by binding regulations or international treaties. Health interests have a 
chance of success against powerful industrial lobbies only at this international level.  
The essential instrument for achieving this is “Health in all policies”. It is not only named in 
the Article 35 of the EU Charter of Fundamental Rights (17), but it is also the most important 
part of the EU legal base for health. Even if today it is still more a vision and not a reality, 
there is hope that at the EU level it can become true. Commissioner David Byrne (18) 
expressed this as follows: “The future of health is not characterized by national isolation but 
by international cooperation, governance, and partnership. A more cooperative, integrative 
and proactive health policy will lead to a more healthy society characterized by enhanced 
economic output and reduced strain on national health care systems”. 
To make this hope come true, it not only needs political will, but also sufficient instruments. 
Does the EU have them? Can they be developed?  The biggest obstacle is the MS‟ attitude as 
described below. 
 
Development of health competence from Maastricht 1992 to Lisbon 2010 
 
Article 129, Treaty of Maastricht, 1992 
The EU “Public health” competence as laid down for the first time in Article 129 of the 
Treaty of Maastricht, often but never substantially changed in the subsequent treaties, fully 
reflects the defensive and negative position of MS. As only a „supportive competence‟ it 
always was and still is the weakest legal base possible – in great contrast to the other strong 
categories such as exclusive or shared competences. It gives the EU no power to establish 
binding legal regulations or directives. Its competence is limited to “carry out actions to 
support, coordinate or supplement the actions of the Member States” according to Article 6 of 
the Treaty on the functioning of the EU (Treaty of Lisbon). The “protection and improvement 
of human health” is on the same unsatisfactory level such as culture or tourism. 
The establishment of a legal base for EU health policy has never been the object of an overall 
plan or strategy of any EU institution. Right from the beginning, there have been permanent 
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conflicts between European activities and differing national positions on the one hand, and 
economic interests versus health needs on the other. In these conflicts, health interests find 
only little support. 
The Europeanization of health policy and the implementation of EU Health competence were 
“A dynamic but still rather unplanned process of policy harmonization and policy adaption. It 
offers an example of effective and inspired muddling through, rather than of a consistent and 
clear cut European concerted strategy” (19). It is worthwhile to take a look at the evolution 
of the legal base of the EU Public Health mandate, especially as today treaty changes are 
being discussed to reduce EU power in favour of increased national responsibility. 
Before the Treaty of Maastricht in 1992, there was no specific legal base for public health 
activities. The first EU action  program „Europe against cancer‟ 1985 initiated by a Summit in 
Rome and, therefore, had to be based on a catch of legal base, in that a Commission proposal 
could be agreed unanimously if the Treaties did not provide the necessary power. This legal 
base still exists today in the Article 352 of the Lisbon Treaty, but it cannot be applied to 
health any more, as there is a specific legal base for public health, established in the Article 
129 of the Treaty of Maastricht in 1992. 
The main components of Article 129 were slightly reworded in the following treaties, but 
essentially are still valid: 
- Community action should encourage and support MS‟ cooperation in order to achieve 
a high level of health protection, and; 
- Community action should be directed towards preventing human illnesses, especially 
by promoting research into their causes, their transmission, as well as health 
information and education. 
 
The only instrument to achieve this, were supportive activities. Consequently the only 
activities that took place were „Action programmes‟ and „Recommendations‟. Any binding 
legal measures such as regulations or directives are impossible. Health Care was not even 
mentioned and MS, especially the new ones, watched very carefully that EU action did not go 
an inch beyond these agreements.  
Quite soon, it became obvious that this very limited and weak mandate and its legal base were 
not sufficient to enable the EU to react appropriately to new challenges or at least to 
contribute sufficiently to their solution. Examples for these new problems, which most MS 
were unable to cope with alone, included new health threats such as AIDS, SARS or Ebola, 
the economic crisis and its effects on health systems, as well as bio-terrorism, to name just a 
few. Regarding one threat, the BSE crisis and the Jacob-Creutzfeld Disease, the Commission 
handling it was paying more attention to the commercial interests of farmers than to health 
risks for humans, which led the European Parliament to demand a strengthening of the public 
health legal base, which took place in a new strengthened formulation in the Article 152 of the 
Treaty of Amsterdam (20), which was not only upheld, but even strengthened in all further 
Treaty changes (Nice 2003, Lisbon 2010). 
 
The Lisbon Treaty 2010 
Many years later, in 2010, the Lisbon Treaty was agreed to and ratified. Its ratification was 
relatively easy because it was not a completely new text but just modified the pre-existing 
Treaty of Nice. It consists of two parts (Treaty of the EU containing common provisions and 
principals and Treaty on the EU functioning) containing the strengthened competences of the 
Commission as proposed in the failed attempt to agree on a European constitution in 2004. 
Despite the permanently ongoing discussion about increasing or decreasing EU competences, 
the necessary changes of the Lisbon Treaty seem highly improbable because the needed 
unanimous agreement and ratification by 28 MS and even more in the future. As the Lisbon 
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Treaty will be the legal base of all EU action for a long time, it is appropriate to look at the 
changes in the health provisions to see how far future challenges could be met by EU 
activities. 
The provisions in the Treaty on the functioning of the EU are peculiar, difficult to understand, 
and even contradictory. Whereas Article 4 mentions health aspects as an area of shared 
competence: “Common safety concerns in public health matters for the aspects defined in this 
Treaty” [2k], the Article 6  also names it as  the first area for supportive, coordinative and  
supplementary  competence : (a) “protection  and improvement  of human health”. 
Health is the only policy area mentioned in two different competence categories. Is there a 
difference between public health and human health? Is there a difference between common 
safety and protection? Most likely this is a badly formulated remnant of the foregoing 
discussion around a constitution, where health as a whole was originally planned to be a 
„shared competence‟, which many MS did not want. The background for a potential shared 
competence was the threat of „Bio-terrorism‟, which was considered to be a common safety 
concern to society and not just a health threat. 
Whatever the explanation may be, as the EU-related contents of Public Health are described 
in great detail in the Title XIV of Article 168, it is obvious that with few exceptions Public 
Health continues to be only a supportive competence, which aims at encouraging and 
supporting MS cooperation. In spite of the detailed description in the Article 168, this leads to 
less and not more clarity. In comparison to the lengthy elaboration of one page in Article 168, 
the really important area Internal Market consists of involves only some lines in Article 26. 
The well-known MS position to keep the EU as far away as possible from influencing their 
health policy is fully upheld. There is no harmonization of systems in any way. There still is  
hardly any possibility for binding hard law legislation (exceptions: Article 168  No. 4 dealing 
with quality and safety of organs and blood, veterinary and phytosanitary fields with direct 
relation to public health, and quality and safety of medicinal products as well as devices). 
However, there are at least some small improvements. The scope and content of the 
Commission support of cooperation, i.e. financing, is increased by naming concrete 
possibilities such as establishment of guidelines and indicators – both basic for the 
establishment of a permanent EU health information system – as well as the organisation of 
the exchange of best practices, periodic monitoring and evaluation. Furthermore, the door for 
the first time is slightly opened for health care as there are positive words about improving the 
complementarities of health services in cross-border areas, something that has been happening 
for a long time in many „EUREGIOS‟ without Commission participation or support. 
 
Health in all Policies (HiaP) 
The most important change, however, is the new first sentence introducing Article 168, also 
contained in Article 35 of the EU Charter of Fundamental Rights: 
 
“A high level of human health protection shall be insured in the definition and 
implementation of all the Unions policies and activities”. 
 
This very clear statement, which gives the EU an undisputable legal right und political 
mandate, is quite unique as it is not contained in any national constitution or bill of human 
rights. It not only means that all other policies have to avoid  or at least limit negative health 
effects, but  it also  provides a legal base to use all policies directly or at least indirectly for 
binding and obligatory  “health  legislation”. It gives the EU the power and the competence to 
establish „hard law‟, to achieve health aims and targets.  
The EU fight against tobacco was the biggest EU health policy success story; it was made 
possible because „hard law‟, based on Internal Market competences, was used to establish the 
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needed binding directives. They were disputed and fought bitterly by the active and powerful 
tobacco lobby, but despite of all their attempts expressively legally confirmed and even 
promoted by a number of European Court decisions. 
Despite of this encouraging example, Health in all Policies today is mainly a vision and far 
away from being an overall reality.  It is tremendously difficult to apply and implement it, as 
other policies which want to achieve their own aims and health impacts, as a rule, are of little 
concern to them. Last but not least, powerful stakeholders – not only industry but also social 
partners – have foremost economic and not health interests and, at a political level, it is the 
economy that counts.  
As an example, the EU strategy to „Reduce alcohol-related harm‟ failed to a great extent 
because of the negative consequences for various other EU policies and regulations 
(agricultural subsidies, harmonisation of taxation and the removal of trade barriers in the 
Internal Market). It is the most prominent example of failure of the HiaP principle. Despite 
the undisputable fact that alcohol is a main cause for diseases and health, the economic 
interests were stronger and prevailed. The EU is worldwide the biggest alcohol producer in a 
growing and very profitable market which had to be safeguarded. Thus, the EU market laws 
weakened the restrictive alcohol policy in the Nordic countries with the result that drinking 
alcohol already in adolescence became their biggest health problem. 
To transform the Health in all Policies principle from vision to reality it is essential to be able 
to compete with and to influence countervailing economic and industrial powers. This 
requires adequate organisational structures as well as institutional mechanisms for resolving 
conflicts and the development and permanent use of support tools such as health impact 
assessment. Above all, it is essential that those who are responsible for health in the 
Commission (Health Commissioner and Health Directorate) and in the MS (Health Ministries 
and stakeholders) have the political will, as well as the power to do it.  All of that is missing 
nowadays in the EU. 
 
Achievements and impact of EU Health Policy                                               
After more than 20 years, it is justified to ask two simple questions: 
i. Have EU activities led to better health in the EU? 
ii. Have EU health actions and health-related legal regulations had a noticeable impact in 
the MS and on the national health policies? 
 
Both questions may be simple, but are difficult to answer. A short, but honest, answer would 
be: We just do not know! As, up to now, no overall evaluation (Health Impact Assessment) of 
EU activities has been made in the EU or in any MS, we can only give some general 
indications based on EU/WHO/OECD health information systems and health monitoring, 
mostly created by EU funding and networks. This enormous increase of knowledge about the 
health situation and health systems and their development, easily available to everyone, is 
possible the biggest achievement of EU health policy, to date. We know today more than ever 
before, but the central question remains: are EU and national policies based on this 
knowledge?  
 
Health Status 
European countries have achieved major gains in population health in recent decades. The 
situation in the EU is better than in most of the other parts of the world. “Life expectancy at 
birth in the EU has increased by more than six years than 1980 to reach 79 years in 2010, 
while premature mortality has reduced dramatically. Over three quarters of these years can 
be expected to be lived free of activity limitation” (21). On average, across the EU, life 
expectancy at birth for the three-year period 2008-10 was 75. 3 years for men and 81.7 years 
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for women. The report explains this situation by “Improved living and working conditions 
and some health-related behaviours, but better access to care and quality of care also 
deserves much credit”. 
The question is, if and how much these factors have been influenced by EU policies. A 
scientific evaluation in 2003 of the  EU “Europe against Cancer Program” (22) comes to the  
conclusion, that this programme appears to have been associated with the avoidance of 92,573 
cancer deaths in the year 2000, or a reduction of about 10% of the EU overall. These exact 
figures might be questioned, but the phrase „appears to have been associated‟ is applicable 
also to the positive EU influence on the overall improvement of the health status of EU 
citizens. There can be little doubt that many EU activities that have been directed at reducing 
risk factors to health, be it tobacco smoking, alcohol consumption or overweight, have 
contributed at least to some extent to their reduction. The reduction of tobacco consumption  
by adults in most EU Member States (examples: 15% in Sweden and Iceland from 30% in 
1980, but still over 30% in Greece, Bulgaria, Ireland and others) would not have happened 
without the EU activities such as  public awareness campaigns, advertising bans, and 
increased taxation. Indeed, the reduction of smoking is the biggest EU Health success story 
until now.  
By influencing mainly non-medical factors, the EU has contributed quite substantially to the 
present positive health status, whereas „governance of health care‟ factors such as proper 
access to health care, number of doctors and nurses, health care spending and the like have 
hardly been effected by  the EU. 
Even if the health status within the EU can be considered to have improved overall, there still 
is the unsolved problem of large and still growing inequalities between different countries. 
The gap between EU-MS with the highest and lowest life expectancy at birth is around eight 
years for women and 12 years for men. But, there is also a large gap within countries mainly 
between socio-economic groups. However, the EU has tried to reduce these gaps, where it 
was not successful. 
 
Impact in Member States 
The process of transforming visions into reality, of developing EU health policy and 
implementing it in the MS had to overcome countless barriers, was not very transparent and 
still is very slow. It has been described by Lamping (19), a German political scientist as 
“Discontinuing, incoherent sometimes fairly accidental  and even undemocratic with little 
logic and rationality , self dynamic, not political but technocratic, determined by interest 
groups, based mainly on voluntary  cooperation with little room for binding legal acts”. 
On the same lines, Hervey and Vanhercke (22) describe EU health policy as “A patch work of 
actors and institutions which decide and implement law, policy, and governance”. They name 
five different domains as components of EU health policy that MS have to improve: Public 
Health, Research (both are soft law areas with no binding obligations to MS), Internal Market, 
Competition, and Social laws. There is no overall leadership and more competition than 
cooperation. Whereas national health policy as a rule is the domain of one political 
administration (the Health Ministry), supported by health experts, the EU health  patch work 
consists of institutional structures and procedures that often were developed for domains that 
have no health  interest at all. As a consequence, EU health is not only not an EU priority but 
also a highly contested area with a permanent conflict between health and economic interests. 
Also, there is only little transparency. EU Health policy is mainly a field for experts with little 
citizens‟ participation. Scott Greer (15) called it a „secret garden‟ which should be turned into 
a „public park‟.  
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Considering the weak legal base, the lack of political commitment and interest of the MS but 
also within the Commission, and the limited financial and personal resources available, the 
amount of health and health-related  activities that have been developed and undertaken by 
this „patch work‟ is quite astonishing. Starting with its first programme “Europe against 
Cancer” in 1985, a countless number of soft law activities (strategies, recommendations, 
programmes, projects, studies, networks, frameworks, concerted actions, establishment of 
agencies, platforms, and committees etc.) have taken place. The amount of binding 
legislations (hard law) is  of course much smaller, the most important being those on tobacco 
issues including advertising, blood safety, pharmaceuticals,  medical devices,  professional 
qualifications, food safety and – the first  small step into health care – the “Patient‟s Rights” 
directive on cross-border health care. The latter was enforced by a number of decisions of the 
European Court of Justice. There is hardly any health problem or major disease that has not 
been the object of EU activities.  
The most comprehensive overview is contained in a “Welcome Package Public Health”, 
prepared in 2009 by the Policy Department “Economic and Scientific Policy” (23) of the 
European Parliament, to serve as a reference tool for incoming Members of the European 
Parliament. A similar document seemingly was not produced for the new European 
Parliament 2014. In more than 120 pages, this document, available on the Internet, names and 
describes all past, ongoing and planned EU activities. The integration of health into other 
policies, however, is described on just one page and these other policies are not even named.  
Furthermore, the document says nothing about the impact on the MS. This is to some degree 
understandable because there is hardly any knowledge about the actual impact of EU health-
related activities on the MS. There is no overall evaluation, no general Health Impact 
Assessment. Of course the many different activities, strategies, programs, and projects, as a 
rule are evaluated, but these evaluations say nothing about their impact. Health impact 
assessments of Health in All Policies are conducted in a small number when new policies and 
regulations are being prepared, not when they have been implemented.   
There is hope for at least a partial improvement in the future. The “Patient Mobility Directive 
2011” not only had to be implemented by the MS until the end of 2013; they also have to 
report to the Commission about what they have done. These reports have to include detailed 
information about patient movements and the cooperation between MS in border regions, 
European reference networks, rare diseases, e-health, and health-technology assessment. As 
of 2015 the Commission has to give an overall report to the Council and the European 
Parliament, we will then know a little more about national impact, at least in some areas. 
Today, we still know only little, actually too little, about the impact of EU Health policy. 
Only a few documents contain information about success or failure: 
 
i. The most negative report is an evaluation conducted by the European Court of 
Auditors in 2009 of the 3
rd
  EU Public Health Programme 2007-2013 (24). This report 
considered it a waste of money, because it contained no strategy, was badly 
implemented, the projects funded had little policy connection, and there was no follow 
up. The Commission accepted this harsh criticism and promised positive changes in its 
future programmes, especially in the following next 4
th
 programme. Also, from 
author‟s experience as a project evaluator it seems justified to say that since 1978 the 
many hundreds, even thousands of projects funded in the various Public Health as well 
as Research Programmes very rarely had relations to political activities, be it in the 
EU, be it in the individual MS. Although it was the expressive aim of all these 
programmes that the funded projects should contribute to the improvement of health 
of the European citizens, it was never really evaluated if and how they achieved this. 
Many of the projects improved knowledge, but only a few led to political action. 
Stein H. The Maastricht Treaty 1992: Taking stock of the past and looking at future perspectives (Review 
article). SEEJPH 2014, posted: 23 December 2014. DOI 10.12908/SEEJPH-2014-36  
 
 
14 
 
 
ii. Surprisingly the most positive document is the “Review of the balance of competences 
between the United Kingdom and the European Union in Health”, published 2013 by 
the UK Government (25). It is part of a comprehensive examination of the balance of 
competences between the UK and the EU to analyse what UK membership means to 
national interest. These documents were prepared for all EU policies to serve as a base 
for negotiations with the EU about a reduction of EU competences, which – if not 
successful – might even lead to the UK to leave the EU. This health review is quite 
remarkable for a number of reasons. It is the only document prepared by any MS 
government describing and evaluating the national impact of EU health activities. It 
not only contains the view of the UK government, but also – this is really unique – the 
views of UK citizens, industry and stakeholders, who were asked to give their opinion.  
Altogether, it was recognized that with very few exceptions the EU in health matters 
had a positive impact especially in Public Health (tobacco use, tackling obesity, 
alcohol abuse), as well as health security (where even more efforts were welcomed), 
sharing of information and data, as well as research funding. Benefits were also seen 
in Internal Market health care measures including the free movement of patients and 
of health professionals, to reduce shortages. Only in a few areas adverse consequences 
of cross sector EU legislation were noted: The directives on clinical trials, data 
protection, and working time. The current balance of competences between EU and 
UK were considered appropriate, but should not be extended further. Considering 
these positive views in a country where generally the EU is looked at in a negative and 
critical way, it may be good to have similar surveys in other countries. 
 
iii. A midterm evaluation about the implementation and impact of the EU Health Strategy 
2008-2013 (26) contains some key conclusions that could be applied to the EU Health 
policy as a whole. It acknowledges that there is a high level of activities at EU and 
Member State  level, but it is uncertain if the outputs at MS level can be attributed 
directly or exclusively to the EU Health Strategy. Thematic or structural  similarities  
between EU and MS activities  were identified but considered to be a reflection of  
similar  priorities, a discernable direct of EU measures was not found, its influence an 
national strategies was considered  limited. The main value of the EU Health Strategy 
was described as follows: “It acts as a guiding framework and to some extent as a 
catalyst for action”. 
 
These findings coincide with the results of a conference on “European Public Health, 20 years 
of Maastricht Treaty“, 2013 in Maastricht (27). It names a number of positive developments 
as the result of EU health policies:  
- Building of a public health infrastructure (agencies & permanent networks); 
- Establishment of the EU as a reference point for policy makers/professionals, i.e. the 
establishment of a change agent for innovation; 
- Demand for capacity building initiating a boom of new education; 
- Development of European-oriented knowledge and skills. 
 
It seems that the highly fragmented EU health policy as it is gradually taking shape has up to 
now only limited, indirect, and even unintended affects often on national health systems and 
policies. It has, however, contributed considerably to the development of Public Health, an 
area which in many MS is underdeveloped and needs this support. 
 
Health and the EU Crisis                                     
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The present EU crisis was not caused by health, but it influences EU health policy and the 
national health systems. The crisis started as a financial and economic one, but it has led to a 
general EU crisis. It still is uncertain, when and how it will be solved, but very likely the 
measures taken to control it will change EU objectives, structures, competences and 
instruments. The future EU will be quite different to the one existing in 2014.   
As early as in April 2012, the former EU Health Commissioner John Dalli, who later was 
forced to retire under still not clarified circumstances, said at a COCIR conference in Brussels 
(28):  “A key challenge we are facing today is to prevent the economic crisis from triggering 
a health crisis. This may sound dramatic but the risk of this should not be underestimated”. 
Largely unnoticed by the media, the public opinion, and by the Public Health Community as 
well, a health crisis soon became a reality in many EU-MS, especially in those which because 
of their critical economic situation received financial aid through the “Economic Adjustment 
Programmes”. Examples of impact and extent of the health crisis are shown by the following 
figures in the “Briefing notes” of the European Public Health Alliance (29):  
- Rise in unemployment in the EU-28 from 7.2% in 2007 to 9.7% in 2010 and 11.0% in 
2013 (Greece 27.5%, Spain 26.2%, and Croatia 17.6%), especially the deterioration of 
youth employment which in 19 of the 28 MS stood at over 20% in 2013. 
- Mental health and suicides rates, which until 2007 had been consistently decreasing 
rose in the EU from 11.4 % in 2007 to 11.8% in 2012, alarming in some MS such as 
Greece, Spain, Ireland and Italy. 
- Cutting health budgets as well as other resources and frequent measures to reduce 
costs in nearly all MS have reduced the availability of frontline services and 
institutions. 
- Austerity measures concerning health professionals such as reducing salaries (pay cuts 
between 10-40%) have led to a growing migration which endangered health services 
in some countries. 
 
All these measures concerning the organisation and delivery of health services belong fully to 
the responsibility of MS, which the European Commission has to respect. Although the 
Treaty and therefore the limited EU health competence – excluding most aspects of health 
care – remain unchanged, the balance of power between the EU and MS in health care is 
changing in favour of the EU as a number of new instruments were created since 2011. They 
are intended to strengthen the EU governance of economic policy but have of course an 
impact also in the health sector. The new instruments should enable the Commission to 
intervene directly in national health care policies from a financial perspective and force 
national health systems to contribute to the achievement of the economic EU goals.  These 
interventions concern not only “crisis states” receiving financial aid from EU, the 
International Monetary Fund, and the European Central Bank, but all MS in the context of a 
common macroeconomic policy.  
Direct interventions by international into national health systems are not within the EU 
competences.  In the past, this kind of interventions has been restricted to developing 
countries receiving financial aid. However, those countries receiving financial aid from the 
EU “Economic Adjustment Programmes” are in a quite similar situation. They have been 
obliged to undertake a wide range of austerity health actions demanded by the so-called 
TROIKA. These austerity measures are not always fully in line with widely accepted health 
values such as full access for everyone and good quality of medical services.  
There are, on the other hand, also EU initiatives that address health care reforms in all MS in 
the context of a common economic policy. These direct interventions are slowly turning into a 
systematic EU surveillance, backed by the power to issue early warnings and to apply even 
sanctions. The most important new legal act that makes this possible is the so-called Fiscal 
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Pact (“Treaty on Stability, Coordination and Governance in the Economic and Monetary 
Union”), agreed by only 25 EU-MS as an intergovernmental agreement which does not 
replace the EU Treaty, but is nevertheless enforced by the Commission. 
The most important tool to improve policy coordination of macro-economic structural issues 
in key policy areas is the “European Semester for economic policy coordination” that was 
launched in 2011. At that time, health was not considered to be a key policy area that had to 
be included. But, this changed in the same year when the Ecofin Council demanded the 
Commission to include health. Since 2012, Health Care is included and considered to be a key 
policy area for economic growth and a permanent part of its five components. Since then, it is 
described in the Annual Growth Survey (AGS), presented every year by the Commission, a 
part of Strategic Advice & Orientations, contained in the “National Reform & Stability 
Convergence Programmes of the Member States”, and the object of Country Specific 
Recommendations given by the Commission and the Ecofin Council (30-33). 
Although the EU Health Competence as laid down in the Treaty is and will remain weak and 
limited mainly to Public Health, denying any EU actions in health care and  health systems, it 
is firmly established as a key policy area of EU macroeconomic policy. All decisions are 
dominated and made by economic actors and structures in all of the European institutions 
with mainly economic interests in mind. Those responsible for health play a minor role in the 
decision making process.  
 
Future perspectives 
An article about the past developments in the EU would not be complete without taking a 
look at future options and perspectives. There is a large number of publications describing and 
criticising EU health policy, but there are hardly any books or scenarios about its possible 
future. Scenarios of the future are manifold. As far as health is concerned, three factors have 
to be taken into account: 
i. The future EU   
ii. New challenges and new solutions 
iii. The role of health in a future EU   
 
The future EU 
The EU is here to stay. There will be changes. The number of its members will continue to 
grow – there seems to be almost no limit. Industrial ties and economic interests will guarantee 
its pertaining future existence. Some countries may leave the EU, the main candidate at the 
moment being the United Kingdom. This for many reasons would have negative effects on 
both sides, especially in Public Health, as the English Public Health Community appears to be 
the strongest one. Growth, however, will also continue to increase problems in two ways.  On 
the on hand, the differences between MS such as size, population, economic  situation, 
resources and the like, will lead to more inequality, for many aspects including health. On the 
other hand, the EU will have to cope with its growth with structures and instruments that were 
designed for a small community of six countries, all of which similar regarding their 
economic situation. 
In order to adapt the EU to be able to better master new challenges and tasks, it is essential to 
change not only its objectives and priorities but also its competences, structures and 
instruments, including a new balance of power between the three institutions - the Council, 
the Commission, and the European Parliament. This normally could only be done by a 
fundamental change of the Lisbon Treaty, however, that is almost impossible, not only right 
now, but also in a foreseeable future. It needs unanimity by all MS and ratification – partly by 
a national referendum – again by all MS. Because of this, the debate about a new treaty, 
Stein H. The Maastricht Treaty 1992: Taking stock of the past and looking at future perspectives (Review 
article). SEEJPH 2014, posted: 23 December 2014. DOI 10.12908/SEEJPH-2014-36  
 
 
17 
 
including the establishment of a Political Union, has stopped. We will have to live with the 
Treaty of Lisbon for a long time. 
The answer possible at the moment – and for some time – can only be a Europe of two 
speeds, in no way a new development. We already have an EU of at least two speeds in areas 
in which not all MS could agree on a common way forward. The Schengen agreement on 
border regulations and the creation of a Monetary Union, establishing the new currency 
EURO in most but not all countries, are the most prominent examples. Lately, and  more 
relevant for the health, is the creation of the Fiscal Union (Treaty on Stability, Coordination 
and Governance) agreed up to 2012 by only 25 MS as an intergovernmental  agreement, part 
of a new economic governance framework. In the future, supranational and intergovernmental 
agreements of this kind outside the EU “Acquis communautaire” and its legal base will partly 
replace the existing EU instruments and influence national policies more than ever before in 
many areas including health.  
The impact of this new situation on national welfare, social as well as health systems, has not 
been considered sufficiently yet. To date, EU and national health authorities play only a minor 
role in this process dominated by economic interests. There is a danger that health values and 
interests could be neglected, especially when they clash directly with economic interests. For 
the future of health it is essential, even vital, to ensure that those  responsible and accountable 
for health policy at the EU as well as national level take part in this process with sufficient 
power to safeguard health interests. 
 
New challenges and new solutions  
 Presently, EU Health policy is faced with two main, totally different challenges:     
- The overall EU crisis mainly caused by economic and financial problems; 
- The outbreak of Ebola, one of the biggest health threats ever. 
 
In both cases, the EU has done too little and too late. Especially in the case of Ebola, the EU 
was badly prepared and, so far, is largely invisible (16). Even the new European Centre for 
Disease Control, founded in 2005, was much too weak to create a common anti-Ebola policy 
of the European Institutions and the MS. As difficult as it may be to master these problems, 
they are at the same time an opportunity to move forward. The development of the EU health 
policy has often been crisis driven. There is justified hope that the new situation will lead to 
new solutions, only possible in a time of crisis.  
In the past, the progress of EU health policy was triggered by new challenges and dangers 
which could not be tackled sufficiently on the grounds of the existing legal base, structures 
and instruments. Communicable disease outbreaks (AIDS and HIV-blood contamination, 
CJD, SARS, and especially BSE posed severe threats to health, similar to bio-terrorism) are 
prominent examples enabling progress that otherwise would not had taken place:  
°   Treaty changes strengthening the EU legal base for Public Health;  
°   The EU Health strategy with strategic objectives and principles;  
°   New organisational structures within the EU;    
°   Shift of competences (food, pharmaceuticals) to health institutions; 
°   Intensification & institutionalisation of new cooperation capacities;  
°   Creation of comprehensive databases & information systems; 
°   Establishment of agencies in health-related areas (altogether nine); 
°   The new instrument of “Open method of Coordination (OMC)”, applied to health;  
°   Closer cooperation of the EU with WHO and OECD. 
 
Most importantly, they brought about changes in the attitude of MS. These were influenced to 
some extent by the needs and expectations of new MS which considered it essential to add 
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health care and finance issues to the EU health agenda. MS still consider health to be, first and 
foremost, national responsibility but there is a slowly growing feeling “…that health policy 
should no longer be discussed exclusively in terms of national autonomy and sovereignty” 
(19). EU power and influence related to “All Other Policies” has already changed the 
environment in which national health policy takes place. As there is also a feeling that many 
problems, be it in health care or fighting new health threats cannot be solved effectively at the 
national level, it is increasingly recognized that the EU health policy is not simply a 
continuation of national health policies, but it is in many ways different.  
 
The legal basis 
A new and more precise formulation of the EU health competence (Article 168) is needed, but 
obviously not possible as it would require a change of the Treaty. However, a new consensus 
could and should be achieved as to how the Article 168 should be interpreted and 
implemented. The EU should not continue to be active in every possible health arena, many of 
which are already sufficiently covered by national health policies. It should concentrate and 
limit itself to those issues, where MS need EU support, because the objectives of the action 
cannot be sufficiently achieved by the MS. This is not new, but simply the subsidiarity 
principle as laid down in the Article 5 of the Treaty, which in the past has been neglected too 
often. If this is done, there is no need to continue the permanent debate about giving EU 
health competences back to the MS. A renationalisation desired by many would take place 
automatically.  
 
Internal structural reforms 
To be better prepared for facing future challenges, structural reforms are essential, which 
include but go far beyond  „Complementing national policies‟ and „Encouraging cooperation 
between MS‟, without intending a harmonisation of national health systems.  
 
These should include: 
i. The internal reorganisation of the Commission which should increase and not 
decrease the areas for which the Health Commissioner is responsible, including all 
those with a priority health interest.  
ii. Increasing, stabilizing,  and institutionalising the EU problem-solving capacities 
by establishing new health agencies (examples: health technology assessment, rare 
diseases, E-health, or health information systems), strengthening the 
administrative power of the existing ones, and creating  new observatories and 
permanent networks in order to improve the diffusion of best practices. 
iii. Advance, even institutionalise, a closer cooperation with WHO and OECD making 
use of their reputation, knowledge, experiences, manpower, worldwide resources 
and avoid double work. In the long run, this should result in a common 
institutionalised Global Health Policy with many partners. 
 
The role of health in a future European Union  
Again, EU health policy is here to stay. It is no longer questioned any more that Public Health 
should remain to be an EU policy of its own. Nobody is demanding any more a total 
renationalisation. Nevertheless, the EU Public Health Policy as such is far away from being or 
becoming a European priority. It is, at best, only a side issue on the European stage with little 
power and low resources. 
But, this is not even half of the story. Health as an issue, not as a policy, has been transformed 
during the past years from a non-topic to one of the most important EU fields. In the main 
stream of EU politics, i.e. policy coordination on macro-economic issues, health has become 
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and will remain a key policy area. This elevation is fully justified considering its economic 
implications and its position in the four freedoms of the Internal Market.  
Nevertheless, the EU Health Policy is and will remain a patch work consisting of many 
different parts and partners. It is a complex cross-cutting policy sector and is part of and 
regulated in a multitude of other policy sectors like environment, consumer protection, 
industry, research, transport, agriculture, competition, information and – most importantly – 
the EU Internal Market policy. Health policy and especially health care are an intrinsic and 
relevant part of the European Market of goods and services, which are affected and partly 
even harmonized via simple market compatibility. The decisions are taken issue-specific, 
fragmented, not very transparent, and mostly guided by economic interests. The EU is 
foremost an economic union and partly even a political one, but not a social union. Health, 
contrary to social progress or environment, is not mentioned as an EU objective in the Lisbon 
Treaty. Health, as a key policy area, is only of interest as long as it is part of another policy 
and has positive or negative economic implications. 
Health authorities within the EU-Commission, the European Parliament, and the Council of 
MS, at best, play only a minor role in the economy dominated decision making process. It is 
obvious that health values and interests could easily be neglected, especially when there is a 
clash with economic interests. It is essential and vital for the role  of  health in a future EU to 
ensure that those accountable and responsible  for health  at the EU and national levels take an 
active part in this decision making process  with sufficient power to safeguard health interests. 
In the past, this was partly achieved by shifting more competences within the Commission 
from agriculture (food), or the Internal Market (free movement of patients and professionals, 
pharmaceuticals) to the Health Directorate. This was much more than just an internal 
organisational act by the Commission because it had consequences for the decision-making 
process in other EU institutions. Whatever belonged to the tasks of the Health Directorate was 
automatically decided by the Health Council and the Health Committee of the European 
Parliament. 
 
Conclusion 
EU health policy as a whole has not been an unequivocal success story: there are weaknesses 
but also strengths. Its main strength is that it has become a permanent part of the European 
integration process. Hardly anyone is demanding its renationalisation anymore. Considering 
its weak legal base, the restrictive position of the MS, and the activities of recognised 
international organisations such as WHO or OECD, it is astonishing to observe what has been 
achieved. A „non-topic‟ has developed into a key policy area of the EU economic policy. This 
is not due to a sudden discovery of the value of Public Health – the esteem for EU action in 
this area is still low – but relies entirely on its economic consequences. However, there is also 
the danger and even to some degree a tendency that the EU health policy might be reduced to 
narrow Public Health issues alone. Therefore, public health activities should not only be 
continued but, in due time, considerably broadened and strengthened. In the future, the main 
task will be to safeguard health interests in „All Areas‟ including economy, to ensure that 
economic interests do not precede health. This task should not be left to Non-Governmental 
Groups, as valuable as their contributions will continue to be, but should be the task of health 
authorities within the Commission and in the MS. To be successful, this requires political 
power as well as adequate organisational structures, giving health authorities more power 
instead of taking it away from them. In addition, it needs scientific evidence that could be 
provided by the EU-funded public health actions and research. If this happens, there is no 
reason to have doubts about a positive future of the EU health policy. 
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